Legal Representation
Attorney
JAY G KOLMAN
USPTO Deadlines
Application History
32 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 28, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jun 28, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Dec 11, 2009 | EX5G | S | EXTENSION 5 GRANTED |
| Nov 30, 2009 | EEXT | I | TEAS EXTENSION RECEIVED |
| Nov 29, 2009 | EXT5 | S | EXTENSION 5 FILED |
| Jun 17, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 17, 2009 | EX4G | S | EXTENSION 4 GRANTED |
| May 28, 2009 | EEXT | I | TEAS EXTENSION RECEIVED |
| May 28, 2009 | EXT4 | S | EXTENSION 4 FILED |
| Nov 25, 2008 | EEXT | I | TEAS EXTENSION RECEIVED |
| Nov 25, 2008 | EXT3 | S | EXTENSION 3 FILED |
| Nov 25, 2008 | EX3G | S | EXTENSION 3 GRANTED |
| Sep 29, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| May 29, 2008 | EEXT | I | TEAS EXTENSION RECEIVED |
| May 29, 2008 | EXT2 | S | EXTENSION 2 FILED |
| May 29, 2008 | EX2G | S | EXTENSION 2 GRANTED |
| Dec 14, 2007 | EX1G | S | EXTENSION 1 GRANTED |
| Nov 28, 2007 | EEXT | I | TEAS EXTENSION RECEIVED |
| Nov 28, 2007 | EXT1 | S | EXTENSION 1 FILED |
| May 29, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 6, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 14, 2007 | NPUB | O | NOTICE OF PUBLICATION |
| Jan 17, 2007 | ALIE | A | ASSIGNED TO LIE |
| Jan 17, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Dec 19, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 15, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Dec 15, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 15, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 15, 2006 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jun 15, 2006 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jun 12, 2006 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 20, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely transdermal and transmucosal delivery systems consisting of a bandage or patch encoded with a unique identifier recognizable by a human or by an electronic or optical device for delivery through skin or mucosa of hormonal and steroidal drugs and substances, drugs and substances having a stimulant or depressant effect on the central nervous system, drugs or substances having a lethal or toxic physiological effect in excess quality or dose, and drugs or substances creating an addictive, habit-forming or dependency effect
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005